by National Cerebral and Cardiovascular Center Credit: Unsplash/CC0 Public Domain “The foot bone’s connected to the ankle bone,” goes the schoolyard song, highlighting the ways in which each part of our body can affect other parts of the body. Now, researchers from Japan have found that the kidney is connected to the heart, in that...
ALPHAMED PRESS IMAGE: NEUROPROTECTIVE EFFECTS OF HUMAN AMNIOTIC FLUID STEM CELL-SECRETOME IN AN I/R MODEL. Durham, NC – A study released today in STEM CELLS Translational Medicine points the way to a possible new avenue of treatment for ischemic stroke. The study, led by Annamaria Cimini, Ph.D., of the University of L’Aquila, and Liborio Stuppia, M.D., of...
Researchers from the University of Tsukuba show that the wives of men with major cardiovascular disease risk factors, namely hypertension, diabetes, and dyslipidemia, are more prone to suffer from the same disorders UNIVERSITY OF TSUKUBA Tsukuba, Japan – Cardiovascular disease is the leading cause of death worldwide, killing nearly 18 million people annually, which is...
THE MOUNT SINAI HOSPITAL / MOUNT SINAI SCHOOL OF MEDICINE PUNEET BELANI, MD, ASSISTANT PROFESSOR, RADIOLOGY AND NEUROSURGERY, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAIview more CREDIT: MOUNT SINAI HEALTH SYSTEM Journal Name: American Journal of Neuroradiology: http://www.ajnr.org/content/ajnr/early/2020/06/25/ajnr.A6650.full.pdf Title of the Article: COVID-19 is an independent risk factor for acute ischemic stroke. Corresponding Author: Puneet...
CHAMPAIGN, Ill. — In regenerative medicine, an ideal treatment for patients whose muscles are damaged from lack of oxygen would be to invigorate them with an injection of their own stem cells. In a new study published in the journal ACS Nano, researchers at the University of Illinois at Urbana-Champaign demonstrated that “nanostimulators” – nanoparticles...
A blood clot forming in the carotid artery. An anti-inflammatory drug given to patients in the early stages of a stroke has been shown by researchers at The University of Manchester and Salford Royal NHS Foundation Trust to reduce harmful inflammation. The drug, Kineret, licenced for treating rheumatoid arthritis, was given as a small...
